Insider Buying: SVP Strategy & Compliance James Sullivan Acquires 9,000 Shares of BIO-key International Inc
Author's Avatar GuruFocus Research 14 hours ago Article's Main Image BKYI ?0.7% On September 11, 2023, James Sullivan, the Senior Vice President of Strategy & Compliance at BIO-key International Inc (BKYI, Financial), purchased 9,000 shares of the company. This move is significant as it indicates the insider's confidence in the company's future prospects.
BIO-key International Inc is a leading provider of biometric identity and access management solutions. The company's innovative software and hardware solutions deliver strong, convenient security, and user-friendly functionality, enabling its customers to enhance productivity and reduce costs.
Over the past year, the insider has purchased a total of 17,618 shares and has not sold any shares. This trend suggests a strong belief in the company's potential for growth and profitability.
1702113373530882048.png The insider transaction history for BIO-key International Inc shows a total of 5 insider buys over the past year, with no insider sells. This trend indicates a positive sentiment among the company's insiders, which could be a bullish signal for investors.
On the day of the insider's recent buy, shares of BIO-key International Inc were trading at $0.53, giving the company a market cap of $4.746 million.
With a price of $0.53 and a GuruFocus Value of $3.02, BIO-key International Inc has a price-to-GF-Value ratio of 0.18. This suggests that the stock is a possible value trap, and investors should think twice before investing.
1702113390006108160.png The GF Value is an intrinsic value estimate developed by GuruFocus. It is calculated based on historical multiples (price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow) that the stock has traded at, a GuruFocus adjustment factor based on the company’s past returns and growth, and future estimates of business performance from Morningstar analysts.
In conclusion, the insider's recent purchase of BIO-key International Inc shares could be a positive signal for the company's future prospects. However, given the stock's current price-to-GF-Value ratio, investors should exercise caution and conduct thorough research before making an investment decision
BIO-key International (NASDAQ:BKYI) Share Price Passes Below 50 Day Moving Average of $0.66 Defense World StaffSep 12th, 2023 BIO-key International logoBIO-key International, Inc. (NASDAQ:BKYI – Get Free Report)’s share price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.66 and traded as low as $0.51. BIO-key International shares last traded at $0.53, with a volume of 26,813 shares changing hands.
BIO-key International Price Performance
The company has a current ratio of 1.36, a quick ratio of 0.66 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $4.89 million, a P/E ratio of -0.47 and a beta of 1.05. The firm has a fifty day moving average of $0.66 and a 200 day moving average of $0.72.
BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its quarterly earnings data on Monday, August 14th. The technology company reported ($0.16) earnings per share for the quarter. The company had revenue of $1.93 million for the quarter. BIO-key International had a negative net margin of 117.65% and a negative return on equity of 122.43%.
About BIO-key International
(Get Free Report) BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.